Slide 1NUOVI APPROCCI TERAPEUTICI NEL CARCINOMA PROSTATICO Alfredo Berruti Dipartimento di Scienze Cliniche e Biologiche Università di Torino Azienda Ospedaliero Universitaria…

Slide 1Triple-Negative Breast Cancer: Lifestyle Changes to Reduce Risk of Recurrence Serena T. Wong, MD Assistant Professor of Medicine Division of Medical Oncology The Cancer…

Slide 1Neil H. Segal, M.D., Ph.D. Assistant Attending Gastrointestinal Oncology Service and Immunotherapeutics Core Memorial Sloan-Kettering Cancer Center Slide 2  MedImmune:…

Slide 1Safety and Efficacy of Denosumab for Giant Cell Tumor of Bone Jean-Yves Blay 1 ; Sant Chawla 2 ; Leanne Seeger 3 ; Robert Henshaw 4 ; Edwin Choy 5 ; Robert Grimer…

Slide 1Circulating Tumor Cells and Their Prognostic and Predictive Value in Breast Cancer Massimo Cristofanilli, M.D., F.A.C.P. Professor and Chairman Medical Oncology G.…

1.Quantitative medicine A “killer app” for grid Ian Foster Computation Institute Argonne National Lab & University of Chicago2. Thanks in particular to … CarlStephanSteveRaviJonathan…

1. New Strategies to Prevent Breast Cancer MetastasisPatricia S. Steeg, Ph.D.Women’s Malignancies BranchNCI 2. Breast Cancer Survival by Subtype, After Initial Metastatic…

1. Brain Metastases in NSCLC Boone Goodgame, MD 2. Case Report #1 3. Case Report #2 4. Overview • Epidemiology & prognosis • Standards of care and current clinical…

1. Clinical Activity of the Oral ALK Inhibitor,Clinical Activity of the Oral ALK Inhibitor, Crizotinib (PF-02341066), in Patients withCrizotinib (PF-02341066), in Patients…

1. GAP - Overall Goal Facilitates and administers MD Anderson's Sister Institution Network (the largest network of cancer centers) working collaboratively on education,…